<DOC>
	<DOCNO>NCT02732665</DOCNO>
	<brief_summary>In study , glycosaminoglycan ( GAG ) profile subject first diagnose metastatic ccRCC hypothesize useful monitor drug response predict outcome CT scan . To end , regularly measure plasmatic urinary GAGs prospectively enrol subject correlate drug response evaluate designated clinician base CT scan . A positive correlation indicate test successfully detect patient respond treatment schedule follow-up CT scan perform . Data extent metastasis ( number metastatic site ) collect assess whether biomarker level correlate accordingly .</brief_summary>
	<brief_title>Glycosaminoglycan Scores Predictive Biomarkers Advanced Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Eastern Cooperative Oncology Group ( ECOG ) performance status 02 Diagnosis renal cell carcinoma clear cell histology Metastatic disease Predicted life expectancy 2 month Patient refer first line drug therapy Standard image evaluation 12 week prior inclusion Planned standard imaging within 16 week start therapy Informed consent Lack proper compliance accept continuous sampling</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>